Abstract
The metabolic syndrome (MetS) is a polygenic multifactorial metabolic disorder with strong socioeconomic influence. MetS has became a worldwide epidemic, that directly increases the risk of cardiovascular diseases and type 2 diabetes mellitus. The human apoE gene, coding Apolipoprotein E, has three common polymorphisms in human population: e2, e3 and e4, which are proved to be associated with impaired lipid metabolism. The contribution of apoE polymorphism to MetS disorders has not been investigated previously in Vojvodina Province, region with the highest number of obese people in Serbia. The aim of this study was to evaluate apoE gene polymorphism in relation to MetS disorders. The healthy control group of 30 individuals and 63 MetS patients were examined for apoE variants in relation to biochemical and anthropometric parameters. The genotypes were determined by PCR–RFLP. Regarding all parameters, significantly higher values were detected in MetS group compared to control. The MetS group of patients had significantly higher frequency of e4 allele. In addition, positive relation was revealed between e4 allele presence and all measured parameters. It was found that the e4 allele was related with a significantly increased OR of MetS disorders according to the International Diabetes Federation definition. These results suggested that e4 allele may act as a one of determinants for development of metabolic syndrome.
Similar content being viewed by others
References
Kassi E, Pervanidou P, Chrousos G (2011) Metabolic syndrome: definitions and controversies. BMC Med 9:48
Cameron AJ, Shaw JE, Zimmet PZ (2004) The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 33:351–375
Dallongeville J, Cottel D, Wagner A, Ducimetiere P, Ruidavets JB, Arveiler D, Bingham A, Ferrieres J, Amouyel P, Meirhaeghe A (2008) The APOA5 TrpI9 allele is associated with metabolic syndrome via its association with plasma triglycerides. BMC Med Genet 9:84
Tao MH, Liu JW, LaMonte MJ, Liu J, Wang L, He Y, Li XY, Wang LN, Ye L (2011) Different associations of apolipoprotein E polymorphism with metabolic syndrome by sex in an elderly Chinese population. Metabolism 60:1488–1496
Đan I, Stokić E, Sakač D, Đan M, Obreht D, Erak M, Jovanović N (2011) Case–control study of apoE gene polymorphism in young CHD patients and controls in the Serbian population. Arch Biol Sci 61(1):89–98
Sima A, Lordan A, Stancu C (2007) Apolipoprotein E polymorphism:a risk factor for metabolic syndrome. Clin Chem Lab Med 45(9):1149–1153
Larson IA, Ordovas JM, DeLuca C (2000) Association of apolipoprotein (Apo)E genotype with plasma apo E levels. Atherosclerosis 148:327–335
Yin M, Zhang L, Sun X, Mao L, Pan J (2010) Lack of apoE causes alteration of cytokines expression in young mice liver. Mol Biol Rep 37:2049–2054
Kypreos KE, Karagiannides I, Fotiadou EH, Karavia EA, Brinkmeier MS, Giakoumi SM, Tsompanidi EM (2009) Mechanisms of obesity and related pathologies: Role of apolipoprotein E in the development of obesity. FEBS J 276:5720–5728
Đan I (2009) ApoE gene polymorphism in patients with coronary heart disease. Master Thesis, University of Novi Sad
Sparks DL, Connor DJ, Sabbagh NM, Petersen RB, Lopez J, Browne P (2006) Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atrovastatin treatment in Alzheimers disease: results of the Alzheimers Disease Cholesterol-Lowering Treatment (ADCLT) trial. Acta Neurol Scand 114(185):3–7
Burt TD, Agan BK, Marconi VC, Wejing HE, Kulkarni H, Mold JE, Cabrois M, Huang Y, Mahley RW, Dolan MJ, McCune JM, Ahuja SK (2008) Apolipoprotein (apo)E4 enhanses HIV-1 cell entry in vitro, and the APOE e4/e4 genotype accelerates HIV disease progression. PNAS 105(25):8718–8723
Toniutto P, Fattovich G, Fabris C, Minisini R, Burlone M, Pravadelli C, Peraro L, Falleti E, Caldera F (2010) Genetic polymorphism at the apolipoprotein E locus affects the outcome of chronic hepatitis B. J Med Virol 82:224–231
Lee KS, Jang Y, Chung Y-K, Chung JH, Oh BH, Hong CH (2010) Relationship between the diagnostic components of metabolic syndrome (MS) and cognition by ApoE genotype in elderly. Arch Gerontol Geriatr 50:69–72
Shcherbak SN (2001) Apolipoprotein E gene polymorphism is not strong risk factor for diabetic neuropathy and retinopathy in Type I diabetes: case-control study. BMC Med Genet 2:8
Micić D, Jorga J, Stokić E, Antić S, Ratković S (2004) National guide for the doctors in primary health care. In: Republic experts for the developing and implementation of guides in clinical practice, Belgrade, Serbia. p 1–22 (in Serbian)
Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC (2002) Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 155:487–495
Singh PP, Singh M, Mastana SS (2006) APOE distribution in world populations with new data from India and the United Kingdom. Ann Hum Biol 33(3):279–308
Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L (1993) Apolipoprotein E polymorphism in a healthy swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 39(10):2125–2129
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative centrifuge. Clin Chem 18:499–502
Sambrook JF, Russel DW (2001) Molecular cloning: a laboratory manual, 3rd Edn edn. Cold Spring Harbour Laboratory Press, New York
Hixon JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545–548
StatSoft, Inc. (2011). STATISTICA (data analysis software system), version 10. www.statsoft.com
Das M, Pal S, Ghosh A (2009) Synergistic effects of ACE (I/D) and ApoE (HhaI) gene polymorphisms among the adult Asian Indians with and without metabolic syndrome. Diabetes Res Clin Pract 86:e58–e61
Olivieri O, Martinelli N, Bassi A et al (2007) ApoE epsilon2/epsilon3/epsilon4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome. Clin Exp Med 7:164–172
Dallongeville J, Lussier-Cacan S, Davignon J (1992) Modulation of plasma triglyceride levels by apoE phenotype: a meta analysis. J Lipid Res 33:447–454
Oh JY, Barret-Connor E (2001) Apolipoprotein E polymorphism and lipid levels differ by gender and family history of diabetes: the Rancho Bernardo Study. Clin Genet 60:132–137
Povel CM, Boer JMA, Imholz S, Dolle MET, Feskens EJM (2011) Genetic variants in lipid metabolism are independently associated with multiple features of the metabolic syndrome. Lipids Health Dis 10:118
Sirvastava N, Achyut BR, Prakash J, Agarwal CG, Pant DC, Mittal B (2008) Association of cholesterol ester transfer protein (TaqIB) and apolipoprotein E (HhaI) gene variants in obesity. Mol Cell Biochem 314:171–177
Volcik Ka, Barkley RA, Hutchinson RG, Mosley TH, Heiss G, Sharrett AR, Ballantyne CM, Boerwinkle E (2006) Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thicknes but not incident coronary heart disease in 12, 491 ARIC study participants. Am J Epidemiol 164:342–348
Acknowledgments
The completion of this study was made possible through the support of all the study participants and the research staff of the study. The study was supported by the Ministry of Education, Science and Technological Development, Republic of Serbia, Grant No. 43002 and The Provincial Secretariat for Science and Technological Development of Vojvodina, Grant No. 114-451-205672011. The authors are grateful to all of those who helped collecting the blood samples: Drita Skrbic nurse at the Department of Endocrinology, Diabetes and Metabolic Disorders, Novi Sad, Serbia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vučinić, N., Djan, I., Stokić, E. et al. Different associations of apoE gene polymorphism with metabolic syndrome in the Vojvodina Province (Serbia). Mol Biol Rep 41, 5221–5227 (2014). https://doi.org/10.1007/s11033-014-3390-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-014-3390-4